Odaily Planet Daily reports that Coherent has announced the signing of a letter of intent with the U.S. Department of Commerce to secure up to $500 million in direct funding under the CHIPS and Science Act to expand advanced manufacturing capacity for AI photonic chips. Coherent stated that this expansion will strengthen the U.S. domestic photonic chip supply chain and support the high-speed data transmission demands of AI computing infrastructure, alleviating communication bottlenecks caused by large-scale AI computations. The company will collaborate with NVIDIA to advance photonic networking and interconnection technologies for AI "data center factories," following NVIDIA’s announcement that it will invest $2 billion in Coherent. (Semiconductor-Today)
Coherent to Expand AI Photonics Chip Capacity with Up to $50M in Direct Funding
KuCoinFlashShare
Summary
Coherent has signed a term sheet with the U.S. Department of Commerce for up to $50 million in direct funding under the CHIPS and Science Act to enhance AI photonics chip production. The project funding aims to expand U.S. manufacturing of AI photonics chips, supporting AI computing infrastructure and improving data center communications. Coherent will partner with NVIDIA, which previously invested $2 billion in the company, to develop optical networking solutions for AI data centers. This initiative aligns with rising trends in AI and crypto, as photonics technology gains momentum in high-performance computing and blockchain applications.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.